Positron Emission Tomography in Determining Stage of Esophageal Cancer

NACompletedINTERVENTIONAL
Enrollment

235

Participants

Timeline

Start Date

November 30, 1999

Primary Completion Date

July 31, 2005

Study Completion Date

January 31, 2009

Conditions
Esophageal Cancer
Interventions
PROCEDURE

conventional surgery

PROCEDURE

positron emission tomography

PROCEDURE

radionuclide imaging

RADIATION

fludeoxyglucose F 18

DRUG

chemotherapy

RADIATION

Radiotherapy

Trial Locations (35)

10021

Memorial Sloan-Kettering Cancer Center, New York

13210

SUNY Upstate Medical University Hospital, Syracuse

15224

Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital, Pittsburgh

21201

Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore

21204

Cancer Center at Greater Baltimore Medical Center, Baltimore

27710

Duke Comprehensive Cancer Center, Durham

29425

Hollings Cancer Center at Medical University of South Carolina, Charleston

33756

Morton Plant Hospital, Clearwater

36688

University of South Alabama Cancer Research Institute, Mobile

37212

Veterans Affairs Medical Center - Tennessee Valley Healthcare System - Nashville Campus, Nashville

38163

University of Tennessee, Memphis, Memphis

44302

McDowell Cancer Center at Akron General Medical Center, Akron

45242

Bethesda North Hospital, Cincinnati

46202

Indiana University Cancer Center, Indianapolis

48073

William Beaumont Hospital - Royal Oak, Royal Oak

63110

Siteman Cancer Center at Barnes-Jewish Hospital, St Louis

75246

Baylor University Medical Center, Dallas

80010

University of Colorado Cancer Center at University of Colorado Health Sciences Center, Aurora

84143

LDS Hospital, Salt Lake City

90027

Tri-Health Good Samaritan Hospital, Cincinnati

92868

Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center, Orange

94115

UCSF Comprehensive Cancer Center, San Francisco

98104

Swedish Cancer Institute at Swedish Medical Center - First Hill Campus, Seattle

35294-3300

Comprehensive Cancer Center at University of Alabama at Birmingham, Birmingham

36640-0460

Mobile Infirmary Medical Center, Mobile

90095-1781

Jonsson Comprehensive Cancer Center at UCLA, Los Angeles

94305-5407

Stanford Cancer Center at Stanford University Medical Center, Stanford

02114

Massachusetts General Hospital Cancer Center, Boston

43210-1240

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University, Columbus

97213-2967

Providence Cancer Center at Providence Portland Medical Center, Portland

15601-2282

Westmoreland Regional Hospital, Greensburg

15212-4772

Allegheny General Hospital, Pittsburgh

15243-1899

St. Clair Memorial Hospital, Pittsburgh

37232-6838

Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center, Nashville

23298-0037

Massey Cancer Center at Virginia Commonwealth University, Richmond

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00004867 - Positron Emission Tomography in Determining Stage of Esophageal Cancer | Biotech Hunter | Biotech Hunter